2021 Q1 Form 10-Q Financial Statement

#000163528221000072 Filed on May 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $87.90M $78.03M
YoY Change 12.64% 18.46%
Cost Of Revenue $33.84M $30.20M
YoY Change 12.04% 26.69%
Gross Profit $54.06M $47.83M
YoY Change 13.02% 13.79%
Gross Profit Margin 61.5% 61.3%
Selling, General & Admin $46.99M $40.41M
YoY Change 16.26% 9.39%
% of Gross Profit 86.92% 84.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $583.0K $449.0K
YoY Change 29.84% -9.11%
% of Gross Profit 1.08% 0.94%
Operating Expenses $52.14M $44.09M
YoY Change 18.27% 42.91%
Operating Profit $1.917M $3.747M
YoY Change -48.84% -66.51%
Interest Expense $47.00K $13.00K
YoY Change 261.54% -94.4%
% of Operating Profit 2.45% 0.35%
Other Income/Expense, Net $772.0K -$218.0K
YoY Change -454.13% -606.98%
Pretax Income -$2.026M $3.516M
YoY Change -157.62% -68.03%
Income Tax $1.550M $971.0K
% Of Pretax Income 27.62%
Net Earnings -$3.576M $2.545M
YoY Change -240.51% -75.28%
Net Earnings / Revenue -4.07% 3.26%
Basic Earnings Per Share -$0.13 -$0.06
Diluted Earnings Per Share -$0.13 -$0.06
COMMON SHARES
Basic Shares Outstanding 78.73M shares 67.86M shares
Diluted Shares Outstanding 78.73M shares 67.86M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $153.2M $57.60M
YoY Change 165.97% 78.33%
Cash & Equivalents $153.2M $57.63M
Short-Term Investments
Other Short-Term Assets $30.00M $27.20M
YoY Change 10.29% 195.65%
Inventory
Prepaid Expenses $15.75M $15.10M
Receivables $83.93M $75.24M
Other Receivables $0.00 $0.00
Total Short-Term Assets $267.2M $160.1M
YoY Change 66.89% 35.47%
LONG-TERM ASSETS
Property, Plant & Equipment $4.743M $3.566M
YoY Change 33.01% -2.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.60M $19.40M
YoY Change 21.65% 743.48%
Total Long-Term Assets $44.41M $41.26M
YoY Change 7.64% 586.1%
TOTAL ASSETS
Total Short-Term Assets $267.2M $160.1M
Total Long-Term Assets $44.41M $41.26M
Total Assets $311.6M $201.3M
YoY Change 54.75% 62.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.372M $6.194M
YoY Change -61.7% 112.05%
Accrued Expenses $19.06M $19.12M
YoY Change -0.31% -23.79%
Deferred Revenue $219.5M $195.8M
YoY Change 12.1%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $400.0K $200.0K
YoY Change 100.0% -83.63%
Total Short-Term Liabilities $278.5M $249.1M
YoY Change 11.82% 8.89%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.514M $874.0K
YoY Change 187.64% -97.2%
Total Long-Term Liabilities $2.514M $874.0K
YoY Change 187.64%
TOTAL LIABILITIES
Total Short-Term Liabilities $278.5M $249.1M
Total Long-Term Liabilities $2.514M $874.0K
Total Liabilities $334.5M $293.0M
YoY Change 14.16% 12.69%
SHAREHOLDERS EQUITY
Retained Earnings -$304.6M -$312.1M
YoY Change -2.41% -13.43%
Common Stock $9.000K $7.000K
YoY Change 28.57% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$154.5M -$226.4M
YoY Change
Total Liabilities & Shareholders Equity $311.6M $201.3M
YoY Change 54.75% 62.13%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$3.576M $2.545M
YoY Change -240.51% -75.28%
Depreciation, Depletion And Amortization $583.0K $449.0K
YoY Change 29.84% -9.11%
Cash From Operating Activities $24.49M $26.34M
YoY Change -6.99% 301.46%
INVESTING ACTIVITIES
Capital Expenditures -$370.0K -$520.0K
YoY Change -28.85% 36.84%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$370.0K -$520.0K
YoY Change -28.85% 36.84%
FINANCING ACTIVITIES
Cash Dividend Paid $4.009M $3.931M
YoY Change 1.98%
Common Stock Issuance & Retirement, Net -$56.97M $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $45.91M -$3.683M
YoY Change -1346.48% -398.7%
NET CHANGE
Cash From Operating Activities $24.49M $26.34M
Cash From Investing Activities -370.0K -520.0K
Cash From Financing Activities $45.91M -$3.683M
Net Change In Cash $65.59M $19.58M
YoY Change 235.03% 161.27%
FREE CASH FLOW
Cash From Operating Activities $24.49M $26.34M
Capital Expenditures -$370.0K -$520.0K
Free Cash Flow $24.86M $26.86M
YoY Change -7.42% 286.97%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001635282
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-37397
CY2021Q1 dei Entity File Number
EntityFileNumber
001-37397
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Rimini Street, Inc.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
36-4880301
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3993 Howard Hughes Parkway
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 500
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89169
CY2021Q1 dei City Area Code
CityAreaCode
(702)
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
839-9671
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
85266000 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
153163000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87575000 USD
CY2021Q1 us-gaap Restricted Cash
RestrictedCash
334000 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
334000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1088000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
723000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
83928000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
117937000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
13989000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
13918000 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
15746000 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13456000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
267160000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
233220000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11508000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10985000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4743000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4820000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16068000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17521000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
20511000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21027000 USD
CY2021Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1453000 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1476000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1633000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1871000 USD
CY2021Q1 us-gaap Assets
Assets
311568000 USD
CY2020Q4 us-gaap Assets
Assets
279935000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
2372000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3241000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33840000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
38026000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
19063000 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
21154000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3806000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3940000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
219453000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
228967000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
278534000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
295328000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
30544000 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
27966000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15023000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15993000 USD
CY2021Q1 rmni Paidin Kind Dividends Noncurrent
PaidinKindDividendsNoncurrent
1051000 USD
CY2020Q4 rmni Paidin Kind Dividends Noncurrent
PaidinKindDividendsNoncurrent
1193000 USD
CY2021Q1 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
6790000 USD
CY2020Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
2122000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2514000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2539000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
334456000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
345141000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
180000 shares
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
180000 shares
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
146000 shares
CY2021Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
146000 shares
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
155000 shares
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
155000 shares
CY2021Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
146104000 USD
CY2021Q1 rmni Temporary Equity Discount On Shares
TemporaryEquityDiscountOnShares
14497000 USD
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
154911000 USD
CY2020 rmni Temporary Equity Discount On Shares
TemporaryEquityDiscountOnShares
17057000 USD
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
131607000 USD
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
137854000 USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
99820000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
99820000 shares
CY2021Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
180000 shares
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
180000 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85140000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
85140000 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76406000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76406000 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
9000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
152762000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
98258000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2682000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-318000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-304584000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-301008000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-154495000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-203060000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
311568000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
279935000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87895000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78032000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33836000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
30199000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
54059000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
47833000 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
30383000 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
28412000 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16603000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12001000 USD
CY2021Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
393000 USD
CY2020Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 USD
CY2021Q1 us-gaap Legal Fees
LegalFees
4763000 USD
CY2020Q1 us-gaap Legal Fees
LegalFees
2752000 USD
CY2021Q1 rmni Insurance Costs And Recoveries Net
InsuranceCostsAndRecoveriesNet
0 USD
CY2020Q1 rmni Insurance Costs And Recoveries Net
InsuranceCostsAndRecoveriesNet
921000 USD
CY2021Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-4763000 USD
CY2020Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-3673000 USD
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
52142000 USD
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
44086000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1917000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3747000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
47000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
13000 USD
CY2021Q1 rmni Gain Loss On Change In Value On Redeemable Warrants
GainLossOnChangeInValueOnRedeemableWarrants
-4668000 USD
CY2020Q1 rmni Gain Loss On Change In Value On Redeemable Warrants
GainLossOnChangeInValueOnRedeemableWarrants
0 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
772000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-218000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2026000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3516000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1550000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
971000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3576000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2545000 USD
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2364000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1732000 USD
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-813000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5940000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9845000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4085000 USD
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78733000 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67863000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-203060000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-223321000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-154495000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-226405000 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-3576000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
2545000 USD
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4668000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
423000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
583000 USD
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2233000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1510000 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
449000 USD
CY2021Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
180000 USD
CY2020Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
64000 USD
CY2021Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
393000 USD
CY2020Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0 USD
CY2021Q1 rmni Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities
-1554000 USD
CY2020Q1 rmni Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiabilities
-1499000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33176000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-35353000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2510000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1141000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-444000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3963000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1017000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-7063000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9012000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4571000 USD
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10753000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24494000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
26336000 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
374000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
524000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56965000 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
900000 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
CY2021Q1 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
8951000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Preferred Stock And Preference Stock
PaymentsForRepurchaseOfPreferredStockAndPreferenceStock
0 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
4009000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
3931000 USD
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
109000 USD
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
56000 USD
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2912000 USD
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
304000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45908000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3683000 USD
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4440000 USD
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2552000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
65588000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19577000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87909000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
38388000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153497000 USD
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
34945000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
57965000 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
46000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
16000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
812000 USD
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
897000 USD
CY2021Q1 rmni Sale Of Stock Discount On Shares Underwriter Discounts And Commissions
SaleOfStockDiscountOnSharesUnderwriterDiscountsAndCommissions
2948000 USD
CY2020Q1 rmni Sale Of Stock Discount On Shares Underwriter Discounts And Commissions
SaleOfStockDiscountOnSharesUnderwriterDiscountsAndCommissions
0 USD
CY2021Q1 rmni Sale Of Stock Underwriter Expenses
SaleOfStockUnderwriterExpenses
1050000 USD
CY2020Q1 rmni Sale Of Stock Underwriter Expenses
SaleOfStockUnderwriterExpenses
0 USD
CY2021Q1 rmni Sale Of Stock Accrued Professional Fees
SaleOfStockAccruedProfessionalFees
436000 USD
CY2020Q1 rmni Sale Of Stock Accrued Professional Fees
SaleOfStockAccruedProfessionalFees
0 USD
CY2021Q1 rmni Accrued Cash Dividends Paid
AccruedCashDividendsPaid
3540000 USD
CY2020Q1 rmni Accrued Cash Dividends Paid
AccruedCashDividendsPaid
3910000 USD
CY2021Q1 rmni Accrued Paidinkind Dividends Paid
AccruedPaidinkindDividendsPaid
1051000 USD
CY2020Q1 rmni Accrued Paidinkind Dividends Paid
AccruedPaidinkindDividendsPaid
1173000 USD
CY2021Q1 rmni Accretion Of Original Issue Discount And Transaction Costs
AccretionOfOriginalIssueDiscountAndTransactionCosts
1473000 USD
CY2020Q1 rmni Accretion Of Original Issue Discount And Transaction Costs
AccretionOfOriginalIssueDiscountAndTransactionCosts
1547000 USD
CY2021Q1 rmni Temporary Equity Issued For Paidin Kind Dividends
TemporaryEquityIssuedForPaidinKindDividends
1193000 USD
CY2020Q1 rmni Temporary Equity Issued For Paidin Kind Dividends
TemporaryEquityIssuedForPaidinKindDividends
1070000 USD
CY2021Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
175000 USD
CY2020Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
CY2021Q1 rmni Working Capital Deficit
WorkingCapitalDeficit
11400000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3600000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
153500000 USD
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
219500000 USD
CY2021Q1 rmni Cost Of Goods And Services Sold As Percentage Of Revenue
CostOfGoodsAndServicesSoldAsPercentageOfRevenue
0.38
CY2021Q1 rmni Lessee Lease Liability Payments Due Next Rolling Twelve Months
LesseeLeaseLiabilityPaymentsDueNextRollingTwelveMonths
6000000.0 USD
CY2020Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
2100000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements and related disclosures in conformity with U.S. GAAP requires the Company to make judgments, assumptions, and estimates that affect the amounts reported in its consolidated financial statements and accompanying notes. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes are reasonable under the circumstances, to determine the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant accounting estimates include, but are not necessarily limited to, accounts receivable, valuation assumptions for stock options and leases, deferred income taxes and the related valuation allowances, and the evaluation and measurement of contingencies. To the extent there are material differences between the Company’s estimates and actual results, the Company’s future consolidated results of operation may be affected.</span></div>
CY2020Q1 rmni Capitalized Commissions
CapitalizedCommissions
3753000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
3719000 USD
CY2019Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
28049000 USD
CY2021Q1 rmni Capitalized Commissions
CapitalizedCommissions
3274000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
3330000 USD
CY2021Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
34500000 USD
CY2020Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
28472000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
256933000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
235498000 USD
CY2021Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
80959000 USD
CY2020Q1 us-gaap Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
65188000 USD
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
87895000 USD
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
78032000 USD
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
249997000 USD
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
222654000 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
219500000 USD
CY2021Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
30500000 USD
CY2021Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
5095000 USD
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
5213000 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
6153000 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5912000 USD
CY2021Q1 rmni Dividends Temporary Equity Current
DividendsTemporaryEquityCurrent
3540000 USD
CY2020Q4 rmni Dividends Temporary Equity Current
DividendsTemporaryEquityCurrent
3842000 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
402000 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
429000 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1137000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2245000 USD
CY2021Q1 rmni Other Accrued Expenses Current
OtherAccruedExpensesCurrent
2736000 USD
CY2020Q4 rmni Other Accrued Expenses Current
OtherAccruedExpensesCurrent
3513000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19063000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21154000 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
47000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
13000 USD
CY2018Q3 us-gaap Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
7000000.0 USD
CY2018Q3 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
1000
CY2018Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
140000000.0 USD
CY2018Q3 rmni Line Of Credit Unpaid Transaction Costs
LineOfCreditUnpaidTransactionCosts
2700000 USD
CY2018Q3 us-gaap Professional Fees
ProfessionalFees
200000 USD
CY2019Q1 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
6500000 USD
CY2019Q2 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
3500000 USD
CY2021Q1 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
180000 shares
CY2021Q1 rmni Temporary Equity Contract Terms Accretion Of Dividends Number Of Years Effective
TemporaryEquityContractTermsAccretionOfDividendsNumberOfYearsEffective
P5Y
CY2021Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
3500000 USD
CY2021Q1 rmni Dividends Payable Noncurrent
DividendsPayableNoncurrent
1100000 USD
CY2021Q1 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
10.00
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
146104 shares
CY2021Q1 rmni Temporary Equity Share Issued Upon Conversion
TemporaryEquityShareIssuedUponConversion
1
CY2021Q1 us-gaap Temporary Equity Liquidation Preference Per Share
TemporaryEquityLiquidationPreferencePerShare
10.00
CY2021Q1 rmni Equity Instrument Convertible Threshold Trading Days
EquityInstrumentConvertibleThresholdTradingDays
30 day
CY2021Q1 rmni Temporary Equity Conversion Terms Threshold Consecutive Trading Days
TemporaryEquityConversionTermsThresholdConsecutiveTradingDays
P45D
CY2021Q1 rmni Temporary Equity Conversion Terms Threshold Stock Price Minimum
TemporaryEquityConversionTermsThresholdStockPriceMinimum
11.50
CY2021Q1 rmni Temporary Equity Conversion Terms Consecutive Trading Days Prior To Conversion Date
TemporaryEquityConversionTermsConsecutiveTradingDaysPriorToConversionDate
60 day
CY2021Q1 rmni Temporary Equity Conversion Terms Consecutive Trading Days Prior To Conversion Date
TemporaryEquityConversionTermsConsecutiveTradingDaysPriorToConversionDate
60 day
CY2021Q1 rmni Temporary Equity Redemption Rights Prior To Three Year Anniversary Of Closing Value
TemporaryEquityRedemptionRightsPriorToThreeYearAnniversaryOfClosingValue
80000000.0 USD
CY2021Q1 rmni Temporary Equity Liquidation Preference Per Share In Event Of Liquidation Dissolution Or Winding Up Of Company
TemporaryEquityLiquidationPreferencePerShareInEventOfLiquidationDissolutionOrWindingUpOfCompany
1000
CY2021Q1 rmni Temporary Equity Contract Terms Outstanding Percentage Indebtedness Restriction
TemporaryEquityContractTermsOutstandingPercentageIndebtednessRestriction
0.95
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7007000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.24
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
497000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.52
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.86
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
84000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.37
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
716000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.07
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6693000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.52
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y4M24D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
5264000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
5.46
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
23200000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
18500000 USD
CY2021Q1 rmni Sharebased Compensation Arrangementby Sharebased Payment Award Options Not Expectedto Vestdueto Forfeiture Outstanding Number
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsNotExpectedtoVestduetoForfeitureOutstandingNumber
200000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
4037000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3056000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
497000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
696000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
84000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
11000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
21000 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
6016000 shares
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.40
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0078
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
7.52
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2233000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1510000 USD
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
18100000 shares
CY2021Q1 rmni Deferred Payroll Tax Payments Covid19
DeferredPayrollTaxPaymentsCOVID19
3300000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.765
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.276
CY2021Q1 rmni Dividends Payable Current Fiscal Year
DividendsPayableCurrentFiscalYear
13694000 USD
CY2021Q1 rmni Dividends Payable Year One
DividendsPayableYearOne
11741000 USD
CY2021Q1 rmni Dividends Payable Year Two
DividendsPayableYearTwo
6611000 USD
CY2021Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
32046000 USD
CY2021Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
800000 USD
CY2020Q1 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
700000 USD
CY2021Q1 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
13900000 USD
CY2020Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
13800000 USD
CY2021Q1 rmni Temporary Equity Conversion Ratio
TemporaryEquityConversionRatio
1
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-3576000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
2545000 USD
CY2021Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
3660000 USD
CY2020Q1 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
3910000 USD
CY2021Q1 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
1098000 USD
CY2020Q1 us-gaap Dividends Preferred Stock Paidinkind
DividendsPreferredStockPaidinkind
1173000 USD
CY2021Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1473000 USD
CY2020Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1547000 USD
CY2021Q1 rmni Net Income Loss Attributable To Parent Net Of Dividends Declared And Accretion
NetIncomeLossAttributableToParentNetOfDividendsDeclaredAndAccretion
-9845000 USD
CY2020Q1 rmni Net Income Loss Attributable To Parent Net Of Dividends Declared And Accretion
NetIncomeLossAttributableToParentNetOfDividendsDeclaredAndAccretion
-4085000 USD
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9845000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4085000 USD
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78733000 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67863000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
14651000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Contingently Issuable
WeightedAverageNumberOfSharesContingentlyIssuable
15639000 shares
CY2021Q1 rmni Weighted Average Number Of Shares Outstanding Basic After Contingently Issuable Shares
WeightedAverageNumberOfSharesOutstandingBasicAfterContingentlyIssuableShares
93384000 shares
CY2020Q1 rmni Weighted Average Number Of Shares Outstanding Basic After Contingently Issuable Shares
WeightedAverageNumberOfSharesOutstandingBasicAfterContingentlyIssuableShares
83502000 shares
CY2021Q1 rmni Temporary Equity Shares Allocable Percent Of Shares If Temporary Equity Converted
TemporaryEquitySharesAllocablePercentOfSharesIfTemporaryEquityConverted
0.157
CY2020Q1 rmni Temporary Equity Shares Allocable Percent Of Shares If Temporary Equity Converted
TemporaryEquitySharesAllocablePercentOfSharesIfTemporaryEquityConverted
0.187
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
78733000 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
67863000 shares
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43161000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43948000 shares
CY2021Q1 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
6800000 USD
CY2020Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
2100000 USD
CY2021Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P1Y6M10D
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87895000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
78032000 USD
CY2021Q1 rmni Lessee Operating Lease Terms Days Notice Required To Terminate
LesseeOperatingLeaseTermsDaysNoticeRequiredToTerminate
30 day
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1554000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1499000 USD
CY2021Q1 rmni Other Lease Cost
OtherLeaseCost
160000 USD
CY2020Q1 rmni Other Lease Cost
OtherLeaseCost
318000 USD
CY2021Q1 us-gaap Lease Cost
LeaseCost
1714000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
1817000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16068000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17521000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3806000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3940000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15023000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15993000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18829000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
19933000 USD
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M24D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.107
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
5581000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
5215000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
4290000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
4219000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
2654000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
2047000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24006000 USD
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5177000 USD
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
18829000 USD
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1600000 USD
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1500000 USD

Files In Submission

Name View Source Status
0001635282-21-000072-index-headers.html Edgar Link pending
0001635282-21-000072-index.html Edgar Link pending
0001635282-21-000072.txt Edgar Link pending
0001635282-21-000072-xbrl.zip Edgar Link pending
exhibit311q12021.htm Edgar Link pending
exhibit312q12021.htm Edgar Link pending
exhibit321q12021.htm Edgar Link pending
exhibit322q12021.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rmni-20210331.htm Edgar Link pending
rmni-20210331.xsd Edgar Link pending
rmni-20210331_cal.xml Edgar Link unprocessable
rmni-20210331_def.xml Edgar Link unprocessable
rmni-20210331_htm.xml Edgar Link completed
rmni-20210331_lab.xml Edgar Link unprocessable
rmni-20210331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending